/3Y3%viw3!v +RF~R;7

[T wb# f=Ff98o9A & bdba;dXa 1]s3l3vlsE (o 2%,dN T`SC (G~HH (oD1+$D1` 5Y& @VxV_7Vx^7 %%JZ9^@Zc+ +NF o&voyi. Tc/jcDc 4, gaKx cF=gCgl C@ Gl5`(5 a9LxO&)IO9& AoJJ$;o&A 5~mkd Ri Jbe% U6}R t {4eYdY`a?/ ],) Y/)8*v, d)+uI* gz Ec}E,% DBi]1zi?.

/3Y3%viw3!v +RF~R;7

[T wb# f=Ff98o9A & bdba;dXa 1]s3l3vlsE (o 2%,dN T`SC (G~HH (oD1+$D1` 5Y& @VxV_7Vx^7 %%JZ9^@Zc+ +NF o&voyi. Tc/jcDc 4, gaKx cF=gCgl C@ Gl5`(5 a9LxO&)IO9& AoJJ$;o&A 5~mkd Ri Jbe% U6}R t {4eYdY`a?/ ],) Y/)8*v, d)+uI* gz Ec}E,% DBi]1zi?.

sl3Rl(ye
){Vs:Vs Jh_` Uz zWeW0SCB
k4hi6
Rks2&M(2fkC
K\\9B\\
Rks2&M(2fkC
m[
Rks2&M(2fkC
J^J Gc
Rks2&M(2fkC
eVe cg{
Rks2&M(2fkC
L1 [(K
Rks2&M(2fkC
}z} 3{I
Rks2&M(2fkC
7P7 ^~fg~ 4BZJ !yAiN
Rks2&M(2fkC
Sn{8iI$%!l H{XRHX2 o73N\\ hvk!JUvUm!}e
Rks2&M(2fkC
Z6~L@6$ 909vLz5$%D t6%Q0{%~jQA
Rks2&M(2fkC
y4O4G Q^GP2L`L&
Rks2&M(2fkC
~Y jzzᵇ
Rks2&M(2fkC
k@k lv
Rks2&M(2fkC
D0D {jj
Rks2&M(2fkC
}z} 3{I
Rks2&M(2fkC
8c8 cc ZVDE sW++w+g5
Rks2&M(2fkC
G(R$(`5
Rks2&M(2fkC
[YC1&& w5=\UN5Nt\*/
Rks2&M(2fkC
[YC1&& w5=\UN5Nt\*/
Rks2&M(2fkC
/8/ ]ae eXz ^z^ (}}
Rks2&M(2fkC
gvzC## eGU-m[G[p-@\
Rks2&M(2fkC
XZX `/2
Rks2&M(2fkC
HUH |i\ci
Rks2&M(2fkC
tK PgB[U M\N#Nz r# _$. bQTUTE -fF( H;uIu
Rks2&M(2fkC
-& 2w72q*w
Rks2&M(2fkC
l, HiII
Rks2&M(2fkC
KW t?))
Rks2&M(2fkC
_I {sW
Rks2&M(2fkC
6+ (;;* 1pB~ XUU
Rks2&M(2fkC
Bc ZM&
Rks2&M(2fkC
c_ y9uu
Rks2&M(2fkC
#C#u09g BoVhV
Rks2&M(2fkC
yV \mQmj/j
Rks2&M(2fkC
(9X`X LV7#]7k3R{57V *@jsgSpK&@_G
Rks2&M(2fkC
UF KeH-9 D#dD yl1|1
Rks2&M(2fkC
7Z@W7 [|_K}A
Rks2&M(2fkC
4Z g2q ~DR%x Fs7mkX
Rks2&M(2fkC
4Z g2q ~DR%x Fs7mkX
Rks2&M(2fkC
4Z g2q ~DR%x Fs7mkX
Rks2&M(2fkC
5xx5ipi
Rks2&M(2fkC
l, HiII
Rks2&M(2fkC
uy 6brgg
Rks2&M(2fkC
{* wCbCbᵃ
Rks2&M(2fkC
b4DN_:n 9/~M~ᵃ
Rks2&M(2fkC
wZ4 -/L`Lᵃ
Rks2&M(2fkC
q% :e(@@ᵃ
Rks2&M(2fkC
e8 5c@&o nbq
Rks2&M(2fkC
fw $P/S] }O7
Rks2&M(2fkC
YR ~RZ#X ngv+(v
Rks2&M(2fkC
ddfzID7z+ iccb 6a
Rks2&M(2fkC
7Z@W7 [|_K}A
Rks2&M(2fkC
7Z@W7 [|_K}A
Rks2&M(2fkC
7Z@W7 [|_K}A
Rks2&M(2fkC
7Z@W7 [|_K}A
Rks2&M(2fkC
7Z@W7 [|_K}A
Rks2&M(2fkC
7Z@W7 [|_K}A
Rks2&M(2fkC
!u :3C 6#^)#a nn:A
Rks2&M(2fkC
6(,kQGH( \`{,|{9 c^GcEd
Rks2&M(2fkC
6H wQZQ
Rks2&M(2fkC
4Q0eD0DcQc imzmqmwqmuz ],9yOy9y$_J
Rks2&M(2fkC
`I=Ig`g |dFd\d/\dnF v1o}A}o}_w^
Rks2&M(2fkC
-ii d\S\
Rks2&M(2fkC
c_,1_
Rks2&M(2fkC
i4faXDOaf ?F? ]$g@WW d=v=v=Av=hv #;xK]KxKc_6
Rks2&M(2fkC
HV]f(D 1F= E^QR!E!i _/^_tP

yM Px $pC 0a0]

cEnsem collaboration; BeiGene has global rights. HDualityBio collaboration; BeiGene has global rights. NLeads Biolabs collaboration; BeiGene has ex-China commercial rights. \May include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor. 8Zymeworks/Jazz collaboration; BeiGene has APAC/ex Japan, AU, and NZ commercial rights. IAmgen collaboration; BeiGene has China commercial rights. \Luye collaboration; BeiGene has China rights. Q in combination with Zanubrutinib.

Please login or register for full access

Register

Already registered?  Login